A Six-Month, Prospective, Single-Center, Pilot Study to Determine the Pharmacokinetics and Effectiveness of Immunosuppressant Regimens in Liver Transplantation Patients Receiving Twice-Daily Tacrolimus and Everolimus (TAC plus EVR BID) Regimen Converted to Once-Daily Tacrolimus and Everolimus (TAC plus EVR QD) Regimen - A Priliminary Report.

Research output: Contribution to journalJournal Article peer-review

Original languageAmerican English
Pages (from-to)842-842
JournalAmerican Journal of Transplantation
Volume18
StatePublished - 2018

Cite this